Devin Whittemore Smith's most recent trade in IO Biotech Inc was a trade of 12,000 Common Stock done at an average price of $0.8 . Disclosure was reported to the exchange on Dec. 23, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
IO Biotech Inc | Whittemore Devin Smith | General Counsel | Purchase of securities on an exchange or from another person at price $ 0.81 per share. | 23 Dec 2024 | 12,000 | 16,938 | - | 0.8 | 9,720 | Common Stock |
IO Biotech Inc | Devin Whittemore Smith | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 185,000 | 185,000 | - | - | Stock Option (Right to Buy) | |
IO Biotech Inc | Devin Whittemore Smith | General Counsel | Grant, award, or other acquisition of securities at price $ 1.90 per share. | 09 Aug 2023 | 4,938 | 4,938 | - | 1.9 | 9,382 | Common Stock |
IO Biotech Inc | Devin Whittemore Smith | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2023 | 4,938 | 4,938 | - | - | Warrants (Right to Buy) | |
IO Biotech Inc | Devin Whittemore Smith | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Minerva Neurosciences Inc | Devin Whittemore Smith | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2020 | 85,000 | 85,000 | - | - | Employee Stock Option (right to buy) | |
Minerva Neurosciences Inc | Devin Whittemore Smith | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 153,531 | 153,531 | - | - | Employee Stock Option (right to buy) |